Thelansis

Acute Disseminated Encephalomyelitis (ADEM) Market Outlook Thelansis’s “Acute Disseminated Encephalomyelitis (ADEM) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Acute Disseminated Encephalomyelitis (ADEM) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which even...

Acute Disseminated Encephalomyelitis (ADEM) Market Outlook Thelansis’s “Acute Disseminated Encephalomyelitis (ADEM) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Acute Disseminated Encephalomyelitis (ADEM) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Acute Disseminated Encephalomyelitis (ADEM) Overview Acute disseminated encephalomyelitis (ADEM) is a rare neurological disorder that affects children more than adults. However, it could affect any age group of the population but can affect anyone. It is characterized by a brief but widespread attack of fibreslammation in the brain and spinal cord that damages m...

  Acute disseminated encephalomyelitis (ADEM) is a rare neurological disorder that affects children more than adults. However, it could affect any age group of the population but can affect anyone. It is characterised by a brief but widespread attack of fibreslammation in the brain and spinal cord that damages myelin, the protective covering of nerve fibres. Symptoms of ADEM rapidly begin with encephalitis symptoms such as fever, nausea, headache, fatigue and vomiting, and in the most serious cases, seizures and coma. ADEM typically causes white matter damage, resulting in neurological symptoms such as visual loss in one or both eyes, weakness, even paralysis, and difficulty coordinating voluntary muscle movements. ADEM is sometimes misdiagnosed as a severe first attack of multiple sclerosis (MS) because the symptoms and appearance of the white matter injury on brain imaging are similar. However, ADEM has several characteristics that set it apart from MS. The incidence of Acute...